Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Strainprint Technologies is a Canadian medical cannabis data and analytics company, positioned as a “demand-side cannabis data and analytics” platform. It started from patient use cases: through its mobile app, users can log cannabis sessions, symptoms, intake methods, dosages, and outcomes, while anonymized aggregate data is then used for research, retail, medical, and industry reporting.
The platform mainly includes Mobile App, Analytics, Reports, and Community. On the patient side, users can track their medication experience, earn Strainpoints rewards, and export PDFs for doctors’ reference. Analytics is designed for researchers, retailers, and licensed producers, supporting real-time user data viewing, research performance monitoring, trend analysis, and therapeutic effectiveness analysis. The reporting service provides both comprehensive reports and custom research. Its data comes from real-time patient records submitted via the free Android and Apple apps. The site mentions tens of thousands of users, more than 2000 lab-verified products/strains, and 12 intake methods, while emphasizing anonymized data, local storage in Canada, military-grade encryption, and compliance with HIPAA, PIPEDA, and PHIPA.
The official website does not publish specific pricing for Analytics. It only states that a Base License can go live within 48 hours, while a White-label License takes about 3 weeks. The mobile app and community are free, and some limited-time reports are also available for free. In terms of integrations, Strainprint can connect with most ERM, ERP, and seed-to-sale systems, and it has deep integration with Ample Organics. Global Data can only be viewed through the web portal, while local data generated through white-label subscriptions can be exported to Excel.
Its strengths are a clearly defined data source, close alignment with real patient usage scenarios, and relatively complete statements around compliance and privacy. It also covers patient logging, industry analytics, research tools, and community features, creating a closed loop. Its limitations are that enterprise pricing is not transparent, and the publicly available product/strain library is only a limited snapshot of the full dataset. The platform also explicitly does not provide medical advice, so users still need professional judgment. In addition, the FAQ mentions that a small number of Android and LG devices may have compatibility issues.
It is better suited to patients in regions where medical cannabis is legal, clinical and real-world research teams, licensed producers, retailers, and industry analysts. For teams in China, the main obstacles are not the typical network issues associated with marketing or SEO tools, but uncertainty around the legality, compliance, payments, and app store availability of cannabis-related businesses. The official website does not provide information on access or payment from China, so this remains unknown. If the goal is simply general marketing or SEO data analysis, locally compliant website analytics, survey, and BI tools should be considered first.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on strainprint.ca official site.
strainprint.ca is an Canada Marketing & SEO provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach strainprint.ca directly.